281 related articles for article (PubMed ID: 24504027)
1. Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.
Sapienza MR; Fuligni F; Agostinelli C; Tripodo C; Righi S; Laginestra MA; Pileri A; Mancini M; Rossi M; Ricci F; Gazzola A; Melle F; Mannu C; Ulbar F; Arpinati M; Paulli M; Maeda T; Gibellini D; Pagano L; Pimpinelli N; Santucci M; Cerroni L; Croce CM; Facchetti F; Piccaluga PP; Pileri SA;
Leukemia; 2014 Aug; 28(8):1606-16. PubMed ID: 24504027
[TBL] [Abstract][Full Text] [Related]
2. Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.
Sapienza MR; Pileri S
Hematol Oncol Clin North Am; 2020 Jun; 34(3):511-521. PubMed ID: 32336416
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm.
Philippe L; Ceroi A; Bôle-Richard E; Jenvrin A; Biichle S; Perrin S; Limat S; Bonnefoy F; Deconinck E; Saas P; Garnache-Ottou F; Angelot-Delettre F
Haematologica; 2017 Nov; 102(11):1861-1868. PubMed ID: 28798071
[TBL] [Abstract][Full Text] [Related]
4. E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell Neoplasm.
Lorenzi L; Lonardi S; Vairo D; Bernardelli A; Tomaselli M; Bugatti M; Licini S; Arisi M; Cerroni L; Tucci A; Vermi W; Giliani SC; Facchetti F
Am J Surg Pathol; 2021 Oct; 45(10):1428-1438. PubMed ID: 34081040
[TBL] [Abstract][Full Text] [Related]
5. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Khoury JD
Curr Hematol Malig Rep; 2018 Dec; 13(6):477-483. PubMed ID: 30350260
[TBL] [Abstract][Full Text] [Related]
6. LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis.
Ceroi A; Masson D; Roggy A; Roumier C; Chagué C; Gauthier T; Philippe L; Lamarthée B; Angelot-Delettre F; Bonnefoy F; Perruche S; Biichle S; Preudhomme C; Macintyre E; Lagrost L; Garnache-Ottou F; Saas P
Blood; 2016 Dec; 128(23):2694-2707. PubMed ID: 27702801
[TBL] [Abstract][Full Text] [Related]
7. Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm.
Kubota S; Tokunaga K; Umezu T; Yokomizo-Nakano T; Sun Y; Oshima M; Tan KT; Yang H; Kanai A; Iwanaga E; Asou N; Maeda T; Nakagata N; Iwama A; Ohyashiki K; Osato M; Sashida G
Nat Commun; 2019 Apr; 10(1):1653. PubMed ID: 30971697
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid dendritic cell expansion in myeloid neoplasms: A novel distinct subset of myeloid neoplasm?
Peng J; He S; Yang X; Huang L; Wei J
Crit Rev Oncol Hematol; 2023 Dec; 192():104186. PubMed ID: 37863402
[TBL] [Abstract][Full Text] [Related]
9. Myeloid Neoplasms with Elevated Plasmacytoid Dendritic Cell Differentiation Reflect the Maturation Process of Dendritic Cells.
Huang Y; Wang Y; Chang Y; Yuan X; Hao L; Shi H; Lai Y; Huang X; Liu Y
Cytometry A; 2020 Jan; 97(1):61-69. PubMed ID: 31876105
[TBL] [Abstract][Full Text] [Related]
10. Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation.
Hamadeh F; Awadallah A; Meyerson HJ; Beck RC
Cytometry B Clin Cytom; 2020 Jan; 98(1):43-51. PubMed ID: 30614203
[TBL] [Abstract][Full Text] [Related]
11. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.
Rauh MJ; Rahman F; Good D; Silverman J; Brennan MK; Dimov N; Liesveld J; Ryan DH; Burack WR; Bennett JM
Leuk Res; 2012 Jan; 36(1):81-6. PubMed ID: 21890199
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical evaluation of BCL-2 expression in acute myeloid leukemia, myeloid sarcoma, and blastic plasmacytoid dendritic cell neoplasm].
Saika W; Kawahara M; Tashiro H; Teramoto Y; Nagai S; Kumode M; Iwasa M; Asai A; Fujishiro A; Nishimura R; Minamiguchi H; Moritani S; Kito K; Andoh A
Rinsho Ketsueki; 2020; 61(12):1647-1653. PubMed ID: 33441515
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.
Wang W; Khoury JD; Miranda RN; Jorgensen JL; Xu J; Loghavi S; Li S; Pemmaraju N; Nguyen T; Medeiros LJ; Wang SA
Haematologica; 2021 Apr; 106(4):1047-1055. PubMed ID: 32241840
[TBL] [Abstract][Full Text] [Related]
14. Newly-Discovered Neural Features Expand the Pathobiological Knowledge of Blastic Plasmacytoid Dendritic Cell Neoplasm.
Sapienza MR; Benvenuto G; Ferracin M; Mazzara S; Fuligni F; Tripodo C; Belmonte B; Fanoni D; Melle F; Motta G; Tabanelli V; Consiglio J; Mazzara V; Del Corvo M; Fiori S; Pileri A; Dellino GI; Cerroni L; Facchetti F; Berti E; Sabattini E; Paulli M; Croce CM; Pileri SA
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572907
[TBL] [Abstract][Full Text] [Related]
15. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
Paluri R; Nabell L; Borak S; Peker D
Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
[TBL] [Abstract][Full Text] [Related]
16. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
Riaz W; Zhang L; Horna P; Sokol L
Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
[TBL] [Abstract][Full Text] [Related]
17. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ
Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional Landscape of CUT-Class Homeobox Genes in Blastic Plasmacytoid Dendritic Cell Neoplasm.
Nagel S; Rand U; Pommerenke C; Meyer C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474011
[TBL] [Abstract][Full Text] [Related]
19. Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.
Xiao W; Chan A; Waarts MR; Mishra T; Liu Y; Cai SF; Yao J; Gao Q; Bowman RL; Koche RP; Csete IS; DelGaudio NL; Derkach A; Baik J; Yanis S; Famulare CA; Patel M; Arcila ME; Stahl M; Rampal RK; Tallman MS; Zhang Y; Dogan A; Goldberg AD; Roshal M; Levine RL
Blood; 2021 Mar; 137(10):1377-1391. PubMed ID: 32871587
[TBL] [Abstract][Full Text] [Related]
20. Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents.
Wang S; Wang X; Liu M; Bai O
Ann Hematol; 2018 Apr; 97(4):563-572. PubMed ID: 29455234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
